GMED

MKT CAP:$13B

Globus Medical, Inc.

Market Cap

$13B

Healthcare·Medical - Devices·🇺🇸 United States·NYSE

Healthcare·Medical - Devices·🇺🇸·NYSE

Stock Price

$93.83+$6.53 (+7.48%)

Apr 21, 2026

Company Details

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion impl...

CEO

Brian J. Kearns

IPO Date

Aug 3, 2012

Website

www.globusmedical.com

Key Metrics TTM

Revenue

$2.9B

+16.7% YoY

Net Income

$538M

EPS (Diluted)

$3.92

Free Cash Flow

$579M

Revenue / Share

$21.42

Gross Margin

67.4%

Operating Margin

16.3%

Net Margin

18.3%

FCF Margin

19.7%

P/S

4.4x

P/E

23.9x

Earnings Reports

Q1 2026

May 14, 2026

PENDING

FY 2025

Feb 24, 2026

$2.9B+16.7%EPS $3.92

Q4 2025

Feb 24, 2026

$826M+25.7%EPS $1.01

Q3 2025

Nov 6, 2025

$769M+22.9%EPS $0.88

Q2 2025

Aug 7, 2025

$745M+18.4%EPS $1.49

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q1 22	$231M	$171M	$46M
Q2 22	$264M	$195M	$68M
Q3 22	$254M	$189M	$60M
Q4 22	$274M	$204M	$54M
Q1 23	$277M	$206M	$56M
Q2 23	$292M	$215M	$66M
Q3 23	$384M	$248M	$404.0K
Q4 23	$617M	$351M	$10M
Q1 24	$607M	$365M	$8M
Q2 24	$630M	$370M	$50M
Q3 24	$626M	$355M	$48M
Q4 24	$657M	$394M	$60M
Q1 25	$598M	$403M	$97M
Q2 25	$745M	$497M	$76M
Q3 25	$769M	$487M	$135M
Q4 25	$826M	$595M	$172M

Valuation

Quarter	P/S	P/E
Q1 22	7.7x	52.4x
Q2 22	6.1x	38.1x
Q3 22	6.1x	39.2x
Q4 22	7.1x	38.1x
Q1 23	5.3x	28.4x
Q2 23	6.0x	32.3x
Q3 23	5.6x	43.3x
Q4 23	4.6x	59.1x
Q1 24	3.8x	107.8x
Q2 24	4.1x	226.5x
Q3 24	3.9x	106.9x
Q4 24	4.5x	109.8x
Q1 25	3.9x	53.3x
Q2 25	3.0x	22.4x
Q3 25	2.8x	18.0x
Q4 25	4.0x	22.1x

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 22	$45M	$25M
Q2 22	$37M	$13M
Q3 22	$33M	$21M
Q4 22	$64M	$46M
Q1 23	$53M	$37M
Q2 23	$35M	$17M
Q3 23	$50M	$29M
Q4 23	$105M	$82M
Q1 24	$52M	$24M
Q2 24	$54M	$26M
Q3 24	$204M	$162M
Q4 24	$210M	$193M
Q1 25	$177M	$136M
Q2 25	$78M	$31M
Q3 25	$250M	$219M
Q4 25	$249M	$192M

Capital Expenditures

Quarter	CapEx
Q1 22	$20M
Q2 22	$24M
Q3 22	$12M
Q4 22	$18M
Q1 23	$16M
Q2 23	$18M
Q3 23	$22M
Q4 23	$23M
Q1 24	$29M
Q2 24	$28M
Q3 24	$42M
Q4 24	$17M
Q1 25	$41M
Q2 25	$47M
Q3 25	$31M
Q4 25	$56M

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 22	+1.4%	+6.5%
Q2 22	+5.0%	-4.5%
Q3 22	+10.6%	+10.2%
Q4 22	+9.8%	-4.9%
Q1 23	+20.0%	+19.7%
Q2 23	+10.6%	+15.1%
Q3 23	+51.0%	+97.1%
Q4 23	+124.6%	+175.1%
Q1 24	+119.3%	+171.8%
Q2 24	+115.9%	+157.3%
Q3 24	+63.1%	+50.7%
Q4 24	+6.6%	-1.5%
Q1 25	-1.4%	-16.3%
Q2 25	+18.4%	+15.4%
Q3 25	+22.9%	+9.8%
Q4 25	+25.7%	+9.7%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 22	$8M	3.5%
Q2 22	$8M	3.0%
Q3 22	$8M	3.3%
Q4 22	$9M	3.1%
Q1 23	$9M	3.2%
Q2 23	$9M	2.9%
Q3 23	$23M	5.9%
Q4 23	$12M	2.0%
Q1 24	$17M	2.8%
Q2 24	$13M	2.0%
Q3 24	$12M	2.0%
Q4 24	$12M	1.8%
Q1 25	$13M	2.2%
Q2 25	$14M	1.8%
Q3 25	$12M	1.5%
Q4 25	$11M	1.4%

OpEx Breakdown

Quarter	R&D	SG&A
Q1 22	$17M	$101M
Q2 22	$17M	$107M
Q3 22	$19M	$107M
Q4 22	$20M	$118M
Q1 23	$21M	$122M
Q2 23	$21M	$120M
Q3 23	$29M	$156M
Q4 23	$52M	$245M
Q1 24	$57M	$249M
Q2 24	$38M	$239M
Q3 24	$35M	$241M
Q4 24	$33M	$253M
Q1 25	$33M	$243M
Q2 25	$40M	$304M
Q3 25	$38M	$314M
Q4 25	$74M	$456M

Revenue Segments

Quarter	Emerging Technology	Spine
Q1 22	$13M	$217M
Q2 22	$29M	$234M
Q3 22	$24M	$230M
Q4 22	$29M	$245M
Q1 23	$25M	$252M
Q2 23	$35M	$257M
Q3 23	$28M	$347M
Q4 23	$33M	$592M
Q1 24	$32M	$575M
Q2 24	$37M	$593M
Q3 24	$38M	$587M
Q4 24	$47M	$610M
Q1 25	$22M	$576M
Q2 25	$35M	$710M
Q3 25	$28M	$741M

Revenue by Geography

Quarter	Non Us	U	United States
Q1 22	$34M	$196M	—
Q2 22	$38M	$225M	—
Q3 22	$37M	$217M	—
Q4 22	$41M	$233M	—
Q1 23	$43M	—	$234M
Q2 23	$46M	—	$245M
Q3 23	$74M	—	$309M
Q4 23	$126M	—	$491M
Q1 24	$124M	—	$483M
Q2 24	$130M	—	$499M
Q3 24	$130M	—	$496M
Q4 24	$135M	—	$522M
Q1 25	$114M	—	$484M
Q2 25	$145M	—	$601M
Q3 25	$151M	—	$618M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 22	$230M	$244M	$473M
Q2 22	$151M	$257M	$408M
Q3 22	$134M	$271M	$405M
Q4 22	$150M	$296M	$446M
Q1 23	$218M	$287M	$504M
Q2 23	$306M	$306M	$613M
Q3 23	$280M	$189M	$469M
Q4 23	$467M	$50M	$518M
Q1 24	$354M	$80M	$434M
Q2 24	$410M	$83M	$493M
Q3 24	$623M	$72M	$695M
Q4 24	$784M	$106M	$890M
Q1 25	$461M	$0	$461M
Q2 25	$229M	$0	$229M
Q3 25	$372M	$19M	$391M
Q4 25	$526M	$31M	$557M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q1 22	104M	-0.1%	+1.6%
Q2 22	103M	-1.1%	-0.6%
Q3 22	101M	-1.4%	-2.9%
Q4 22	102M	+0.8%	-1.9%
Q1 23	102M	-0.0%	-1.8%
Q2 23	102M	-0.4%	-1.1%
Q3 23	115M	+13.2%	+13.6%
Q4 23	139M	+20.6%	+36.0%
Q1 24	135M	-2.6%	+32.4%
Q2 24	137M	+1.2%	+34.6%
Q3 24	138M	+0.8%	+19.8%
Q4 24	140M	+1.2%	+0.5%
Q1 25	140M	+0.0%	+3.3%
Q2 25	136M	-2.3%	-0.4%
Q3 25	135M	-0.8%	-1.9%
Q4 25	137M	+1.3%	-1.8%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q1 22	$96.1K	2K
Q2 22	$109.9K	2K
Q3 22	$105.9K	2K
Q4 22	$105.6K	3K
Q1 23	$106.4K	3K
Q2 23	$112.2K	3K
Q3 23	$147.6K	3K
Q4 23	$123.3K	5K
Q1 24	$121.3K	5K
Q2 24	$125.9K	5K
Q3 24	$125.1K	5K
Q4 24	$82.2K	8K
Q1 25	$74.8K	8K
Q2 25	$93.2K	8K
Q3 25	$96.1K	8K
Q4 25	$103.3K	8K

Revenue / Employee